Pharma News By Region

LEO Pharma announced that it appointed Chris Posner Executive Vice President Region US and President & CEO, LEO Pharma, Inc. President Region US and President & CEO, LEO Pharma, Inc.   From July 15, 2017, he will be responsible for the US business of LEO Pharma, a global healthcare company…
Teva Pharmaceutical Industries Ltd announced the launch of generic Glumetza®1 (metformin hydrochloride extended-release tablets), 500 mg and 1000 mg, in the U.S. Metformin hydrochloride extended-release tablets are used with diet and exercise to help control high blood sugar in adults with type 2 diabetes mellitus. Metformin hydrochloride extended-release tablets are…
ANI Pharmaceuticals, Inc. announced the launch of Pindolol Tablets, 5mg and 10mg, which is used in the treatment of hypertension. The annual U.S. market for Pindolol Tablets is approximately $10 million, per IMS Health. Arthur S. Przybyl, ANI’s President and CEO stated, “We are excited to launch the first product…
Takeda Pharmaceutical Company Limited announced that ALUNBRIG™ (brigatinib) has received Accelerated Approval from the U.S. Food and Drug Administration (FDA) for the treatment of patients with anaplastic lymphoma kinase-positive (ALK+) metastatic non-small cell lung cancer (NSCLC) who have progressed on or are intolerant to crizotinib. This indication is approved under…
Intralytix, Inc. announced that the Company is partnering with BioPhage Therapeutics Limited to develop and commercialize topical bacteriophage treatments of human wounds infected or colonized with S. aureus. "Treatment of bacteria-infected wounds is one the most critical problems in modern medicine. Infected wounds complicate healing, often necessitate repeated surgical interventions,…
Page 1 of 60

Subscribe To Our Newsletter

Security Q:How many eyes has a typical person? (ex: 1)
Name:
Email: